Trump Administration Rule Change Funnels Extra $18.6 Billion to Medicare Advantage Insurers

The Trump administration has finalized a regulation that will direct an additional $18.6 billion to Medicare Advantage health insurers over the next decade. The windfall comes from a significant reduction in the number of quality and care measures used to grade the plans' star ratings, a move that provides a major financial buffer for the industry. The final rule, released by the Centers for Medicare and Medicaid Services (CMS), is substantially more lucrative for insurers than the agency's initial $13.2 billion estimate made last November.

The regulatory change arrives at a critical moment for Medicare Advantage plans, which are currently facing pressure from higher-than-expected medical claims and are awaiting the government's final payment rates for 2027. The industry has been actively lobbying Trump administration officials for increased baseline payments and for a rollback of changes to how they document patient illnesses. The star ratings system directly influences the bonus payments insurers receive, making this reduction in metrics a direct financial boon.

The finalization of this rule intensifies scrutiny on the relationship between federal health officials and the insurance lobby ahead of another key deadline. The government is required to release the separate payment rate regulation for 2027 by April 6, a decision that will further define the financial landscape for Medicare Advantage. This sequence of regulatory actions signals substantial industry influence over the program's financial mechanics during a period of rising healthcare costs.